You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Remission Duration

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Type 2 Diabetes Trial in Pittsburgh (Glargine, Lispro, Dexcom G6)

Completed
Has Results
  • Type 2 Diabetes Mellitus
  • Pittsburgh, Pennsylvania
    UPMC Falk Diabetes Clinic
Sep 15, 2021

Immune Thrombocytopenia Trial (Avatrombopag 20 mg Oral Tablet)

Withdrawn
  • Immune Thrombocytopenia
  • Avatrombopag 20 mg Oral Tablet
  • (no location specified)
Oct 15, 2021

Charcot Joint of Foot Trial in Chandigarh (Danosumab)

Active, not recruiting
  • Charcot Joint of Foot
  • Chandigarh, India
    Deptt of Endocrinology
Mar 21, 2023

Netherlands Cohort Study on Acute HIV Infection

Recruiting
  • Acute HIV Infection
    • Amsterdam, Noord-Holland, Netherlands
      Amsterdam UMC, location AMC
    Feb 6, 2023

    Remission of Acute Charcot-Neuroarthropathy of Foot.

    Recruiting
    • Acute Charcot Neuroarthropathy
    • Total conatact cast
    • Chandigarh, India
      PGIMER
    Aug 23, 2023

    HER2-positive Metastatic Breast Cancer, Stage IV Breast Cancer Trial in Miami (Discontinuation of Anti-HER-2 Maintenance

    Recruiting
    • HER2-positive Metastatic Breast Cancer
    • Stage IV Breast Cancer
    • Discontinuation of Anti-HER-2 Maintenance Treatment
    • Miami, Florida
      University of Miami
    Jul 17, 2023

    Alkylating Agent-Related Acute Myeloid Leukemia, Secondary Acute Myeloid Leukemia Trial in Houston (Laboratory Biomarker

    Completed
    Has Results
    • Alkylating Agent-Related Acute Myeloid Leukemia
    • Secondary Acute Myeloid Leukemia
    • Houston, Texas
      M D Anderson Cancer Center
    Oct 18, 2022

    Systemic Lupus Erythematosus Trial in Germany (Treat-to-target as a new treatment concept)

    Not yet recruiting
    • Systemic Lupus Erythematosus
    • Treat-to-target as a new treatment concept
    • Freiburg, Baden Wurttemberg, Germany
    • +13 more
    Jan 25, 2023

    Recurrent Cervical Carcinoma, Persistent Advanced Cervical Carcinoma, Chemo Trial in Beijing (A combination of anti-PD-1

    Completed
    • Recurrent Cervical Carcinoma
    • +4 more
    • A combination of anti-PD-1 antibody camrelizumab and albumin-bound paclitaxel
    • Beijing, Beijing, China
      Lei Li
    Mar 12, 2022

    Acute Myeloid Leukemia in Remission, FLT3 Gene Mutation, Hematologic and Lymphocytic Disorder Trial in Houston (Azacitidine,

    Recruiting
    • Acute Myeloid Leukemia in Remission
    • +5 more
    • Houston, Texas
      M D Anderson Cancer Center
    Dec 13, 2022

    Type 2 Diabetes, Obesity Trial in Berlin (weight loss by very low energy diet intake which may differ in protein or carbohydrate

    Enrolling by invitation
    • Type 2 Diabetes Mellitus
    • Obesity
    • weight loss by very low energy diet intake which may differ in protein or carbohydrate content
    • Berlin, Germany
      Charité Campus Benjamin Franklin
    Mar 15, 2022

    Gynecological Symptoms and Health-related Quality of Life in

    Recruiting
    • SLE
    • Menstrual Irregularity
      • Fayoum, Fayoum University Zone, Egypt
      • +1 more
      Apr 8, 2022

      Eosinophilic Granulomatosis With Polyangiitis Trial in Paris (Rituximab, Azathioprine, Placebo-rituximab)

      Recruiting
      • Eosinophilic Granulomatosis With Polyangiitis
      • Paris, France
        Hôpital Cochin
      Feb 9, 2022

      Acute Myeloid Leukemia (AML) in Remission Trial in Suzhou (Azacitidine, Venetoclax, Supportive care)

      Recruiting
      • Acute Myeloid Leukemia (AML) in Remission
      • Suzhou, Jiangsu, China
      • +1 more
      Aug 18, 2022

      Non-radiographic Axial Spondyloarthritis Trial (Secukinumab, Placebo)

      Not yet recruiting
      • Non-radiographic Axial Spondyloarthritis
      • (no location specified)
      Nov 16, 2022

      B-Cell Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia Trial in Tampa (Tecartus)

      Recruiting
      • B-Cell Lymphoblastic Leukemia
      • Acute Lymphoblastic Leukemia
      • Tampa, Florida
        Moffitt Cancer Center
      Nov 28, 2023

      Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Trial in Worldwide (procedure, other, drug)

      Recruiting
      • Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
      • Biospecimen Collection
      • +4 more
      • Birmingham, Alabama
      • +170 more
      Jan 30, 2023

      Diabetes, Bariatric Surgery, Metformin Trial in France (drug, other, dietary supplement)

      Recruiting
      • Diabetes
      • +2 more
      • Amiens, France
      • +15 more
      May 12, 2022

      Relapsed/Refractory Philadelphia Positive B-precursor ALL Trial in Worldwide (Blinatumomab)

      Completed
      Has Results
      • Relapsed/Refractory Philadelphia Positive B-precursor ALL
      • Duarte, California
      • +21 more
      Sep 8, 2022

      Hematological Malignancies Trial in United Kingdom, United States (Magrolimab, Azacitidine)

      Active, not recruiting
      • Hematological Malignancies
      • Duarte, California
      • +26 more
      Dec 7, 2022

      Ustekinumab Among Bio-naive Crohn's Disease in China

      Not yet recruiting
      • Crohn Disease
      • Hangzhou, Zhejiang, China
      • +2 more
      Oct 9, 2023

      Inflammatory Disease, Disease Crohn, Bowel Disease Trial in Amsterdam (Infliximab subcutaneous, Immunosuppressive Agents)

      Recruiting
      • Inflammatory Disease
      • +2 more
      • Infliximab subcutaneous
      • Immunosuppressive Agents
      • Amsterdam, North Holland, Netherlands
        Amsterdam UMC AMC
      Sep 27, 2023

      Newly Diagnosed Acute Myeloid Leukemia (AML) Trial in Chengdu (SKLB1028 Dose Escalation)

      Recruiting
      • Newly Diagnosed Acute Myeloid Leukemia (AML)
      • SKLB1028 Dose Escalation
      • Chengdu, China
        West China Hospital of Sichuan University
      Jun 30, 2022

      B-cell Acute Lymphoblastic Leukemia Trial in Tampa, Durham, Winston-Salem (Blinatumomab)

      Withdrawn
      • B-cell Acute Lymphoblastic Leukemia
      • Tampa, Florida
      • +2 more
      Feb 14, 2022

      Diffuse Large B-cell Lymphoma Trial in Changchun (Mitoxantrone HCl liposome injection, RiTUXimab Injection, Cyclophosphamid)

      Not yet recruiting
      • Diffuse Large B-cell Lymphoma
      • Mitoxantrone hydrochloride liposome injection
      • +4 more
      • Changchun, Jilin, China
        The First Bethune Hospital of Jilin University
      Aug 15, 2023